Is Dementia a Mental Illness or Neurological Condition?

Dementia is classified as a neurological condition, driven by physical disease processes in the brain. But the question isn’t as cleanly settled as that sentence suggests. The psychiatric symptoms that accompany dementia are so frequent and so central to the experience of the disease that international diagnostic manuals have historically placed it in chapters alongside mental disorders. The real answer lies in how the boundary between “neurological” and “mental” has shifted over time, and why that boundary was always more of a convenience than a scientific fact.

How Diagnostic Manuals Actually Classify Dementia

The two major classification systems used worldwide have taken slightly different approaches to dementia, and both have recently updated their language. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, widely known as the DSM-5, replaced the old term “dementia” with “major neurocognitive disorder.” This wasn’t just cosmetic. The DSM-5 created a unified framework that groups delirium, mild cognitive impairment, and what used to be called dementia under the umbrella of “neurocognitive disorders,” then sorts them by severity and by cause, whether that’s Alzheimer’s disease, vascular disease, Lewy body disease, frontotemporal degeneration, or something else entirely.¹ The shift in terminology was deliberate: it signaled that these are conditions defined by cognitive decline with identifiable brain-based causes, not by the psychological disturbances that accompany them.

The ICD-11, the World Health Organization’s diagnostic system, kept “dementia” as a term but reorganized it within its own “neurocognitive disorders” chapter. It also added severity levels and gave more prominent coding to the behavioral and psychological symptoms that come with dementia, allowing clinicians to capture the full picture in a single diagnosis.² Both systems land in roughly the same place: dementia is recognized as a condition with neurological roots, but one that demands attention to psychiatric symptoms as part of its clinical reality.

The DSM is worth pausing on here, because it’s the manual most associated with psychiatric diagnosis. Earlier editions did list dementia alongside conditions like schizophrenia and depression, contributing to the impression that dementia was a mental illness in the traditional sense. The reclassification into “neurocognitive disorders” was partly a correction of that impression, driven by decades of research into the brain pathology underlying these conditions.³

What Is Actually Happening in the Brain

The reason dementia is now firmly categorized as neurological comes down to what researchers can see in brain tissue. Alzheimer’s disease, the most common form of dementia, is defined by the buildup of two abnormal proteins: beta-amyloid, which clumps into plaques between neurons, and tau, which tangles inside neurons. These aren’t abstract markers. They physically destroy brain cells and disrupt the connections between them. But Alzheimer’s is just one member of a larger family of diseases. Lewy body dementia involves clumps of a different protein. Vascular dementia results from damage to blood vessels supplying the brain. Frontotemporal dementia involves yet another pattern of protein accumulation that attacks the frontal and temporal lobes.⁴

In the group of diseases known as tauopathies, the tau protein becomes abnormally modified, detaches from the structural scaffolding inside neurons, and accumulates into aggregates that progressively kill cells.⁵ These are measurable, physical disease processes. No one debates whether a stroke is a neurological condition; the vascular damage that causes vascular dementia is the same kind of concrete, tissue-level injury. This biological grounding is what separates dementia from conditions like depression or anxiety, where the underlying brain changes are more diffuse and less structurally visible.

Why Dementia Looks So Much Like Mental Illness

Here’s where the clean distinction starts to unravel. The behavioral and psychological symptoms of dementia are not rare complications that happen to a few unlucky patients. They are a core part of the disease experience for the majority of people living with it. A systematic review of community-dwelling dementia patients found that apathy, depression, anxiety, irritability, agitation, sleep problems, and eating disturbances each affected more than one in five patients.⁶ Apathy alone was found in roughly a third of pooled samples. A study in Singapore found that about two-thirds of people with dementia had at least one behavioral or psychological symptom, and nearly a third had experienced three or more in the past month.⁷

These aren’t vague personality changes. They include delusions, hallucinations, paranoia, and aggression. One clinical study found delusions and paranoid thinking in more than half of patients examined, hallucinations in a third, and aggressive symptoms in three-quarters.⁸ If you encountered someone with delusions, hallucinations, and aggression without knowing their diagnosis, your first thought would almost certainly be a psychiatric condition. The symptoms are essentially identical to what you’d see in psychotic disorders, depressive episodes, or severe anxiety states.

And these psychiatric symptoms aren’t just superficial overlaps. Research has found that psychosis in Alzheimer’s disease is tied to higher densities of the very plaques and tangles that define the disease. Patients with psychotic symptoms had more brain pathology in key regions, along with disrupted levels of specific neurotransmitters, including reduced serotonin.⁹ The psychiatric symptoms don’t come from nowhere; they are produced by the same neurodegeneration that causes the cognitive decline. The brain damage itself generates experiences that are indistinguishable from mental illness.

Misdiagnosis Goes Both Ways

The overlap between dementia and psychiatric disorders isn’t just a theoretical problem. It leads to real diagnostic confusion that can delay the right treatment by years. Behavioral variant frontotemporal dementia (bvFTD) is especially treacherous. This form of dementia primarily attacks the brain’s frontal lobes, which govern personality, social behavior, impulse control, and emotional regulation. Early symptoms tend to be behavioral rather than cognitive: patients become impulsive, lose empathy, develop compulsive habits, or show emotional flatness. Memory may be relatively preserved at first. The result is that roughly half of bvFTD patients receive a psychiatric diagnosis before the correct one, with average diagnostic delays of five to six years from symptom onset.¹⁰

A Colombian study found that over 70% of bvFTD patients were initially misdiagnosed with a psychiatric disease at their first hospital visit. Women were most often labeled with depression or bipolar disorder, while men were more frequently diagnosed with anxiety disorders or psychotic disorders.¹¹ Younger patients are especially vulnerable to this kind of misdiagnosis, because clinicians simply don’t expect dementia in a 45-year-old.¹²

The reverse problem is equally real. Severe depression can cause cognitive symptoms so pronounced that they mimic dementia, a phenomenon sometimes called pseudodementia. A person with major depression may show poor concentration, slowed thinking, and apparent memory loss that looks like early Alzheimer’s. The two conditions are distinguishable, though it takes careful evaluation. People with depression tend to be distressed by their memory problems and highlight them, while people with dementia often minimize or deny them. On memory testing, depressed patients tend to adopt a cautious strategy, missing real items rather than generating false ones, while Alzheimer’s patients frequently endorse incorrect answers.^{13 14} Getting this distinction right matters enormously, because depression-related cognitive symptoms are treatable and often fully reversible, while neurodegenerative dementia is not.

The Neurological-Psychiatric Divide Was Always Artificial

The division between neurology and psychiatry has deep roots in the history of medicine, but it was never a clean split based on biology. The traditional framing went something like this: neurological conditions have identifiable structural or chemical brain abnormalities (tumors, strokes, protein aggregates), while psychiatric conditions are “functional,” meaning the brain looks normal on imaging but something is wrong with how it operates. This distinction was useful in the era before modern neuroimaging and molecular biology. It is increasingly hard to defend now.

Research has shown that this functional-versus-organic divide often contradicts what we actually know about how neuropsychiatric disorders work. Most conditions involve a dynamic interplay between brain pathology, personal history, and social context, and drawing a hard line between the two categories can obscure rather than clarify what’s going on.¹⁵ Depression, for example, involves measurable changes in brain structure and neurotransmitter systems. Schizophrenia involves identifiable differences in brain volume and connectivity. These aren’t “purely psychological” any more than dementia is “purely neurological.”

The emerging field of behavioral neurology and neuropsychiatry sits directly at this intersection, training clinicians to treat brain disease and psychological symptoms as aspects of a single problem rather than as two separate domains requiring two separate specialists.¹⁶ For people with dementia, this kind of integrated thinking is especially important, because their day-to-day suffering often has more to do with behavioral symptoms than with memory loss itself.

Treatment Draws From Both Sides of the Divide

If dementia were purely a neurological condition with no psychiatric relevance, you’d expect its treatment to come entirely from neurology. That’s not what happens. Managing dementia in practice requires tools from psychiatry, psychology, and neurology working together.

Antipsychotic medications, originally developed for schizophrenia, are commonly prescribed for the psychotic symptoms, aggression, and agitation that accompany dementia. A review of meta-analyses found that these drugs show modest benefit for those specific symptoms but carry meaningful risks, including increased sedation, falls, and even mortality. Current guidance reserves them for severe symptoms that haven’t responded to non-drug approaches.¹⁷

On the psychological side, cognitive-behavioral therapy adapted for dementia patients has shown promise. A randomized controlled trial of CBT for people with mild Alzheimer’s disease found significant improvements in clinician-rated depression at one-year follow-up, along with gains in apathy, relationship quality, and quality of life as rated by caregivers.¹⁸ Case studies have also documented the usefulness of adapted CBT for treating anxiety in dementia patients.¹⁹ The fact that a psychological therapy originally designed for depression and anxiety can meaningfully help people with a neurodegenerative disease underscores how artificial the neurological-versus-psychiatric boundary really is in clinical practice.

Genetic Evidence Blurs the Line Further

Recent genetic research has found that dementia and psychiatric disorders don’t just look similar on the surface. They share some of the same genetic architecture. A genetic correlation analysis identified fifteen regions of the genome shared between Alzheimer’s disease and depression, and two regions shared between Alzheimer’s disease and bipolar disorder.²⁰ Frontotemporal dementia shows its own pattern of genetic overlap with psychiatric conditions.²¹

This doesn’t mean depression causes Alzheimer’s, or that they’re the same disease. But it does suggest that some of the biological pathways involved in one can contribute to the other. This kind of genetic pleiotropy, where the same stretch of DNA influences multiple seemingly different conditions, is increasingly common across medicine. It complicates any attempt to draw a neat line between “brain diseases” and “mental illnesses” and reinforces the idea that these categories reflect how we organize medical specialties more than how biology actually works.

How Culture Shapes Whether Dementia Is Seen as “Mental”

How people classify dementia depends a lot on where they live and what their culture tells them about the mind. In many communities worldwide, memory loss in old age is simply considered a normal part of getting older, not a medical condition at all. Other cultural frameworks attribute symptoms to spiritual causes or view them as punishment. These beliefs shape whether families seek medical help, how early they seek it, and whether they’re willing to accept a diagnosis when one is offered.^{22 23}

Stigma also plays a role in whether dementia is treated as a neurological or psychiatric issue. In China, the standard term for dementia (chidai) carries implications about cognitive capability and moral standing that go well beyond a clinical description. The label itself functions as a source of excess stigma, discouraging families from seeking evaluation.²⁴ In contexts where mental illness carries more stigma than neurological disease, families may strongly prefer a “neurological” label because it implies the person is sick rather than “crazy.” In other contexts, any brain-related diagnosis carries shame regardless of which medical department issues it.

These cultural dynamics aren’t separate from the medical question. They directly affect whether people get diagnosed, how they’re treated, and how much support they receive. A clinician working with a patient whose family views dementia as a shameful mental condition needs a different approach than one working with a family that sees it as a brain disease akin to Parkinson’s. The classification debate has consequences that extend well beyond the pages of diagnostic manuals.

What This Means If You or a Family Member Is Affected

For someone navigating the healthcare system, the neurological-versus-psychiatric question has a few practical implications worth knowing. Dementia care typically begins with a neurologist or a geriatrician who evaluates cognitive function, orders brain imaging, and sometimes runs blood-based biomarker tests that can detect abnormal proteins associated with Alzheimer’s disease. But if the dominant symptoms are behavioral, such as personality changes, impulsivity, social withdrawal, or emotional blunting, the path to diagnosis may pass through a psychiatrist first. That’s not necessarily wrong, as long as the psychiatrist keeps dementia in their differential.

If a loved one has been diagnosed with a psychiatric condition like depression or bipolar disorder but you notice progressive cognitive decline, difficulty with everyday tasks, or a pattern of symptoms that worsens over months and years rather than waxing and waning, it is worth asking the treating clinician whether a neurodegenerative condition should be considered. The five- to six-year average delay in diagnosing bvFTD represents real lost time for families who could have been planning, accessing support services, and making legal and financial arrangements earlier.

Insurance coverage and legal protections can also hinge on classification. In many healthcare systems, neurological conditions and psychiatric conditions have different coverage rules, different provider networks, and different thresholds for disability determinations. Whether dementia is treated as one or the other in your specific context can affect what care is accessible and what is covered. Advocacy organizations have long argued that the neurological classification should prevail precisely because it tends to provide better access to medical services and less stigma in institutional settings.

The honest scientific picture is that dementia is a neurological condition that produces psychiatric symptoms as a direct consequence of brain damage. It belongs in both camps in the sense that treating it well requires expertise from both fields. The category you put it in matters less than whether the person gets comprehensive care that addresses the full range of what the disease does to their brain, their behavior, and their daily life.